AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
185,70 € ↓ -2,40 (-1,28%)
2026-06-02
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionOarsman Capital, Inc.
Latest Disclosed Ownership19,598 shares
Latest Disclosed Value $ 4,262,393
Oarsman Capital, Inc. reports 2.84% increase in ownership of 4AB / AbbVie Inc.

On April 27, 2026 - Oarsman Capital, Inc. filed a 13F-HR form disclosing ownership of 19,598 shares of AbbVie Inc. (DE:4AB) valued at $3,633,469 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 19,056 shares of AbbVie Inc.. This represents a change in shares of 2.84% during the quarter. The current value of the position is $3,639,349 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-27 2026-03-31 13F ABBVIE INC COM Stock 00287Y109 19,598 542 2.84 4,262 -2.11 0.5291
2026-02-13 2025-12-31 13F ABBVIE INC COM Stock 00287Y109 19,056 825 4.53 4,354 3.15 0.5650
2025-11-21 2025-09-30 13F ABBVIE INC COM Stock 00287Y109 18,231 508 2.87 4,221 28.34 0.5918
2025-08-01 2025-06-30 13F ABBVIE INC COM Stock 00287Y109 17,723 121 0.69 3,290 -10.82 0.5158
2025-05-14 2025-03-31 13F ABBVIE INC COM Stock 00287Y109 17,602 -15 -0.09 3,688 17.83 0.6625
2025-02-13 2024-12-31 13F ABBVIE INC COM Stock 00287Y109 17,617 -1,471 -7.71 3,131 -16.95 0.5454
2024-11-08 2024-09-30 13F ABBVIE INC COM Stock 00287Y109 19,088 306 1.63 3,769 17.01 0.6939
2024-08-12 2024-06-30 13F ABBVIE INC COM Stock 00287Y109 18,782 1,232 7.02 3,221 0.81 0.7053
2024-05-15 2024-03-31 13F ABBVIE INC COM Stock 00287Y109 17,550 -5,738 -24.64 3,196 -11.45 0.7635
2024-02-16 2023-12-31 13F ABBVIE INC COM Stock 00287Y109 23,288 797 3.54 3,609 7.64 0.9578
2023-10-27 2023-09-30 13F ABBVIE INC COM Stock 00287Y109 22,491 127 0.57 3,352 11.25 1.4009
2023-08-10 2023-06-30 13F ABBVIE INC COM Stock 00287Y109 22,364 -2,059 -8.43 3,013 -22.58 1.3191
2023-05-11 2023-03-31 13F ABBVIE INC COM Stock 00287Y109 24,423 470 1.96 3,892 0.54 1.8194
2023-02-09 2022-12-31 13F ABBVIE INC COM Stock 00287Y109 23,953 -743 -3.01 3,871 16.81 1.9761
2022-11-10 2022-09-30 13F ABBVIE INC COM Stock 00287Y109 24,696 66 0.27 3,314 -12.14 1.7760
2022-08-10 2022-06-30 13F AbbVie COM 00287Y109 24,630 -2,245 -8.35 3,772 -13.43 1.8731
2022-05-11 2022-03-31 13F AbbVie COM 00287Y109 26,875 -1,597 -5.61 4,357 13.02 1.7016
2022-02-10 2021-12-31 13F AbbVie COM 00287Y109 28,472 -1,988 -6.53 3,855 17.32 1.5198
2021-11-12 2021-09-30 13F AbbVie COM 00287Y109 30,460 -28 -0.09 3,286 -4.31 1.3301
2021-08-12 2021-06-30 13F AbbVie COM 00287Y109 30,488 -1,352 -4.25 3,434 -0.35 1.3643
2021-05-12 2021-03-31 13F AbbVie COM 00287Y109 31,840 -5,011 -13.60 3,446 -12.74 1.4910
2021-02-11 2020-12-31 13F AbbVie COM 00287Y109 36,851 -2,264 -5.79 3,949 15.27 1.5343
2020-11-12 2020-09-30 13F AbbVie COM 00287Y109 39,115 -1,016 -2.53 3,426 -13.05 1.5437
2020-08-13 2020-06-30 13F AbbVie COM 00287Y109 40,131 19,555 95.04 3,940 151.28 1.9470
2020-05-13 2020-03-31 13F AbbVie COM 00287Y109 20,576 -16,123 -43.93 1,568 -51.74 1.4480
2020-02-13 2019-12-31 13F AbbVie COM 00287Y109 36,699 1,929 5.55 3,249 23.40 1.4852
2019-11-12 2019-09-30 13F AbbVie COM 00287Y109 34,770 1,887 5.74 2,633 10.12 1.2531
2019-08-13 2019-06-30 13F AbbVie COM 00287Y109 32,883 -65 -0.20 2,391 -9.94 1.0836
2019-05-14 2019-03-31 13F AbbVie COM 00287Y109 32,948 -12,989 -28.28 2,655 -37.31 1.2612
2019-02-13 2018-12-31 13F AbbVie COM 00287Y109 45,937 1,087 2.42 4,235 -0.17 2.1702
2018-11-07 2018-09-30 13F AbbVie COM 00287Y109 44,850 144 0.32 4,242 2.41 1.7084
2018-08-10 2018-06-30 13F AbbVie COM 00287Y109 44,706 1,555 3.60 4,142 1.42 1.8819
2018-05-14 2018-03-31 13F AbbVie COM 00287Y109 43,151 -1,220 -2.75 4,084 -4.82 1.8589
2018-02-08 2017-12-31 13F AbbVie COM 00287Y109 44,371 -347 -0.78 4,291 7.98 1.8471
2017-11-13 2017-09-30 13F AbbVie COM 00287Y109 44,718 1,492 3.45 3,974 26.80 1.6798
2017-08-10 2017-06-30 13F AbbVie COM 00287Y109 43,226 1,191 2.83 3,134 14.42 1.4329
2017-05-11 2017-03-31 13F AbbVie COM 00287Y109 42,035 5,094 13.79 2,739 18.42 1.2748
2017-02-09 2016-12-31 13F AbbVie COM 00287Y109 36,941 -3,736 -9.18 2,313 -9.86 1.4894
2016-11-10 2016-09-30 13F AbbVie COM 00287Y109 40,677 444 1.10 2,566 3.01 1.3086
2016-08-12 2016-06-30 13F AbbVie COM 00287Y109 40,233 1,154 2.95 2,491 11.60 1.2947
2016-05-12 2016-03-31 13F AbbVie COM 00287Y109 39,079 13,666 53.78 2,232 48.31 1.1871
2016-02-11 2015-12-31 13F AbbVie COM 00287Y109 25,413 345 1.38 1,505 10.34 0.8422
2015-11-10 2015-09-30 13F AbbVie COM 00287Y109 25,068 4 0.02 1,364 -19.00 0.8061
2015-08-13 2015-06-30 13F AbbVie COM 00287Y109 25,064 469 1.91 1,684 16.94 1.1484
2015-05-14 2015-03-31 13F AbbVie COM 00287Y109 24,595 -34 -0.14 1,440 -10.67 0.9945
2015-02-06 2014-12-31 13F AbbVie COM 00287Y109 24,629 -315 -1.26 1,612 11.87 1.1618
2014-11-06 2014-09-30 13F AbbVie COM 00287Y109 24,944 676 2.79 1,441 5.18 1.0622
2014-08-08 2014-06-30 13F AbbVie COM 00287Y109 24,268 1,663 7.36 1,370 17.90 0.9939
2014-04-25 2014-03-31 13F AbbVie COM 00287Y109 22,605 1 0.00 1,162 -2.68 0.8970
2014-02-06 2013-12-31 13F AbbVie COM 00287Y109 22,604 11 0.05 1,194 18.10 0.9586
2013-11-13 2013-09-30 13F AbbVie COM 00287Y109 22,593 901 4.15 1,011 12.71 0.8827
2013-08-08 2013-06-30 13F AbbVie COM 00287Y109 21,692 21,692 897 0.8488
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.